Advertisement

Topics

Companies Related to "PTHrP and Osteoporosis" [Most Relevant Company Matches] RSS

18:21 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "PTHrP and Osteoporosis" found in our extensive corporate database of over 50,000 company records.

Showing "PTHrP Osteoporosis" Companies 1–25 of 83

Relevant

National Osteoporosis Foundation

Established in 1984, the National Osteoporosis Foundation is the leading consumer and community-focused health organization dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of public and clinician awareness, education, advocacy and research. For more information, visit www.nof.org or call 1 (8...


Tarsa Therapeutics, Inc.

Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that inhibits bone resorption, the process underlying osteoporosis. Availability of an oral formulation is expected to generate wider use of this established osteoporosis treatment, which currently is available only in injectable and intranasal formulations. Tarsa's oral calcit...

BoneSupport AB,

Osteoporosis is one of today’s most widespread diseases. One in two women and one in four men develops this degenerative condition. Fractures are common consequences, often resulting in a reduction in quality of life. The cost to society is burdensome, and it is expected to grow explosively as populations age. BoneSupport™ is a Scandinavian medical technology company dedicated to th...


Ostex International Incorporated

Ostex International is engaged in the discovery and commercialization of products associated with osteoporosis and other collagen-related diseases. The Company believes that its lead product, the OSTEOMARK-Registered Trademark- test, now available in multiple test formats, incorporates breakthrough and patented technology for the management and prevention of osteoporosis.

Oregon Osteoporosis Center

The Oregon Osteoporosis Center was founded in 1980 and has two locations in Portland, Oregon, one in Vancouver, Washington, and one in Salem, Oregon. The Center provides a comprehensive program focusing on the evaluation and management of patients with osteoporosis, with four major components:A consultative clinic for the care of patients with or at risk for osteoporosis and other metabolic bone d...

BONIVA, PPI

BONIVA is a prescription medicine used to treat or prevent osteoporosis in women after menopause. BONIVA may reverse bone loss by stopping more loss of bone and increasing bone mass in most women who take it, even though they won't be able to see or feel a difference. BONIVA may help lower the chances of breaking bones (fractures). For BONIVA to treat or prevent osteoporosis, you have to take it a...

Osteometer MediTech, Inc

Osteometer A/S was founded in 1989 by Dr. Claus Christiansen and Dr. Bente Juel Riis on the basis of 25 years of research within osteoporosis. For more than two decades Dr. Claus Christiansen has been involved in internationally recognized research on the problems of the postmenopausal woman. He has specialized in the disease of brittle bones (osteoporosis) and bone diseases in general. The main g...

Essentys AB

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly.The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data su...

Osteoporosis Personal Trainer

International Osteoporosis Foundation (IOF)

Zelos Therapeutics Inc.

Zelos Therapeutics is an emerging private biopharmaceutical development company that is commercializing breakthrough discoveries in parathyroid hormone (PTH) research. The company is developing medications for the treatment of osteoporosis, psoriasis and for enhancing engraftment following stem cell transplantation. During 2005, Zelos Therapeutics experienced a number of significant milestones. Ke...

Probably Relevant

Osteologix Inc.

Osteologix develops proprietary therapeutics for the treatment of unmet medical needs in bone disease and women's health. The Company's lead product, NB S101, is being evaluated in a phase II clinical trial for the treatment of osteoporosis. Based on the Company's own data as well as data from phase III clinical trials conducted on a similar drug that is a...

Hologic

Hologic is a leading developer, manufacturer and supplier of premium diagnostic and medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications. Our core business units are focused on osteoporosis assessment, mammography and breast biopsy, direct-to-digital x-...

Osteologix, Inc.

Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of diseases of bone and joint tissues. Its lead product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. Osteologix has completed a Phase II clinical trial of NB S101 that ...

Immunodiagnostic Systems Ltd. (IDS Ltd.)

SBA Sciences is a Finnish company developing novel immunoassays for bone metabolism studies and diagnostics.BoneTRAP® kit has been developed for detection of bone metastasis and follow up of osteoporosis treatment.

Unigene Laboratories, Inc.

Unigene Laboratories, Inc. is a biopharmaceutical company focusing on the oral and nasal delivery of large-market peptide drugs. Due to the size of the worldwide osteoporosis market, Unigene is targeting its initial efforts on developing calcitonin and PTH-based therapies. Fortical®, Unigene's nasal calcitonin product for the treatment of postmenopausal...

Radius Health

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. Radius has raised $106.5 million in private equity financing since its establishment in 2003 and is based in Cambridge, Massachusetts.

Ceros Limited

Ceros Pharmaceuticals is developing compounds to treat osteoporosis. The company is developing important new drug targets that control bone mass and is now in pre-clinical development of compounds. Please contact us to obtain detailed information.

IDS Ltd

From its establishment in 1977, simply as a Distributor of diagnostic products, IDS has become a globally-recognised innovator and marketeer in the IVD industry.The Company is particularly well-known for its expertise in creating tools to aid in the diagnosis of diseases of Bone & Calcium dysfunction (osteoporosis; osteomalacia; Paget's disease), in monitoring response to therapy, and, indeed, in ...

NPS Pharmaceuticals

NPS Pharmaceuticals is engaged in the discovery, development and commercialization of therapeutic small molecules and recombinant proteins to treat bone and mineral, gastrointestinal and central nervous system disorders. History of Successful Drug Discovery NPS has a history of successful drug discovery. With one approved product on the market and several more in development, NPS's discovery capab...

Roche Biosciences

Today Roche Bioscience researchers are focused on the discovery and delivery of new medicines to treat the following diseases:Alzheimer's disease HIV/AIDS Arthritis Incontinence Asthma Osteoporosis Anxiety Overactive bladder Auto-immune disorders Benign prostatic hyperplasia Depression Pelvic hypersensitivity Emphysema and chronic bronchitis Schizophrenia Hepatitis C

Enobia Pharma

Enobia Pharma, a privately held Canadian Biotech company located in Montreal, was created in 1997 with a portfolio of technologies discovered at the University of Montreal. Enobia Pharma’s three main programs focus on the identification and development of specific therapies for bone disorders.The goal of the first program is to demonstrate the therapeutic benefit of enzyme replacement therapy in...

Azelon Pharmaceuticals, Inc.

Azelon Pharmaceuticals is focused on the development of novel formulations for the treatment of osteoporosis. Its lead program, ZT-034, a nasal spray formulation of teriparatide (PTH1-34), offers a convenient alternative for patients at high risk of fracture. Led by an experienced team of biopharmaceutical executives and funded by leading venture cap...

EffRx Pharmaceuticals EffRx Pharmaceuticals SA

EffRx Pharmaceuticals SA is a Swiss-based commercial-stage pharmaceutical company developing and commercializing prescription medications for specialty indications. Our lead commercialized product, Binosto® (buffered soluble alendronate 70mg) is indicated for the treatment of osteoporosis and marketed in US, Europe and Asia. We strive to address true un...

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that help people live longer, healthier and more active lives. Lilly products treat <!--LGfEGNT2Lhm-->depression, <!--LGfEGNT2Lhm-->schizophrenia, attention-deficit hyperactivity disorder, dia...


More From BioPortfolio on "PTHrP and Osteoporosis"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks